BioCentury | Jul 13, 2015
Clinical News
Tendoncel: Phase II data
...Tendoncel for 21 days significantly improved DASH scores by 70% and PRTEE scores by 74%. Tendoncel...
...serious adverse events or changes in IgE levels. Cell Therapy Ltd. , Cardiff, U.K. Product: Tendoncel...
...serious adverse events or changes in IgE levels. Cell Therapy Ltd. , Cardiff, U.K. Product: Tendoncel...